Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CD19 CAR-T cells-Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd-acute lymphoblastic leukemia
- Development stage
- Unknown
- Lead developer
- Shanghai Unicar-Therapy Bio-medicine Technology
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Parenteral
01
Overview
Investigational **CD19-directed chimeric antigen receptor T-cell therapy** sponsored by Shanghai Unicar-Therapy Bio-medicine Technology for CD19-positive acute lymphoblastic leukemia. The registered consolidation study identifies the intervention only as \"CD19 CAR-T cells\" and evaluates it with separately administered CD19-positive feeder T cells in patients with acute lymphoblastic leukemia in remission; no unique product name, proprietary development code, CAR construct sequence, or commercial brand has been publicly disclosed for this exact intervention. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05381662?tab=researcher))
02
Targets
Beyond the preview
Go deeper on CD19 CAR-T cells-Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd-acute lymphoblastic leukemia.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CD19 CAR-T cells-Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd-acute lymphoblastic leukemia.